Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.
| Manufacturer ▼ | Drug Name | Indication | Stage | Status | Route of Administration | Drug Class |
|---|---|---|---|---|---|---|
| GSK plc American Depositary Shares (Each representing two) | Lete-cel - (IGNYTE-ESO) | Sarcoma | BLA Filing | Data Released | Intravenous | Oncology |
| GSK plc American Depositary Shares (Each representing two) | S-Trimer COVID-19 Vaccine + CpG 1018 adjuvant plus alum - (SPECTRA) | COVID-19 vaccine | Phase 2/3 | Data Released | Intramuscular | COVID-19 |
| GSK plc American Depositary Shares (Each representing two) | Bebtelovimab (LY-CoV1404) and Sotrovimab (VIR-7831 / GSK4182136) - (BLAZE-4) | COVID-19 antibody | Phase 2 | Trial Completed | Intravenous | COVID-19 |
| GSK plc American Depositary Shares (Each representing two) | Zejula (niraparib) and Jemperli (dostarlimab) - (FIRST-ENGOT-OV44) | First line advanced ovarian cancer | Phase 3 | Data Released | Zejula oral Jemperli intravenous | Oncology |
| GSK plc American Depositary Shares (Each representing two) | Bepirovirsen (IONIS-HBVRx) | Chronic hepatitis B virus (CHB) | NDA Filing | Data Released | Subcutaneous | Antiviral |
| GSK plc American Depositary Shares (Each representing two) | Xevudy (sotrovimab/VIR-7831) - (COMET-PEAK) | COVID-19 | Phase 2 | Trial Discontinued | Intravenous | COVID-19 |
| GSK plc American Depositary Shares (Each representing two) | GSK3359609 and KEYTRUDA (pembrolizumab) - (INDUCE-4) | Head and Neck Squamous Cell Carcinoma | Phase 2 | Intravenous | Oncology | |
| GSK plc American Depositary Shares (Each representing two) | Ventolin (salbutamol) | Metered dose inhaler (MDI) | Phase 3 | Data Released | Inhalation | Respiratory |
